BiotechTube
Home/Inthera Bioscience/Catherine Ammann
CA

Catherine Ammann

Head HR & Administration

Inthera Bioscience

Therapeutic Areas

Oncology

Inthera Bioscience Pipeline

DrugIndicationPhase
INTH-454Advanced Prostate Cancer (CRPC) and Colorectal Cancer (CRC)IND-ready / Pre-clinical

Leadership Team at Inthera Bioscience

MK
Mark Krul
Chief Executive Officer
BH
Bernd Hentsch, PhD
Chief Development Officer
KA
Kim Andersen, PhD
Head of Drug Discovery
FH
Frank Hennecke, PhD
Head of CMC Development
View full Inthera Bioscience profile